BCIM
GSK icon

Black Creek Investment Management’s GSK GSK Stock Holding History

Black Creek Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,366,879
Closed -$401M – 39
2022
Q1 		$401M Sell
7,366,879
-932,275
-11% -$50.6M 11.3% 4
2021
Q4 		$457M Buy
8,299,154
+35,675
+0.4% +$1.86M 12.2% 2
2021
Q3 		$395M Buy
8,263,479
+993,983
+14% +$49.9M 11.46% 3
2021
Q2 		$362M Buy
7,269,496
+334,697
+5% +$16.1M 11.19% 3
2021
Q1 		$309M Buy
6,934,799
+980,350
+16% +$44.5M 10.25% 4
2020
Q4 		$274M Buy
5,954,449
+765,748
+15% +$35.2M 8.54% 5
2020
Q3 		$244M Buy
5,188,701
+551,748
+12% +$27.6M 9.28% 4
2020
Q2 		$236M Sell
4,636,953
-320,437
-6% -$16.4M 9.55% 4
2020
Q1 		$235M Sell
4,957,390
-849,190
-15% -$45.3M 9.43% 3
2019
Q4 		$341M Sell
5,806,580
-82,467
-1% -$4.59M 10.71% 1
2019
Q3 		$314M Sell
5,889,047
-472,254
-7% -$24.3M 10.99% 1
2019
Q2 		$318M Buy
6,361,301
+10,256
+0.2% +$515K 10.49% 1
2019
Q1 		$332M Buy
6,351,045
+306,522
+5% +$15.3M 11.32% 1
2018
Q4 		$289M Buy
6,044,523
+927,560
+18% +$45.7M 10.45% 1
2018
Q3 		$257M Buy
5,116,963
+13,072
+0.3% +$664K 7.82% 6
2018
Q2 		$257M Buy
5,103,891
+207,938
+4% +$10.5M 7.84% 6
2018
Q1 		$239M Buy
+4,895,953
New +$228M 7.82% 6

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Black Creek Investment Management's GSK Position: Q2 2022 in Review

Black Creek Investment Management sold out of GSK (GSK) in Q2 2022, closing a stake of 7,366,879 shares — an estimated $401M sold.

Black Creek Investment Management first reported a position in GSK in Q1 2018 and held it in 17 quarters. The position peaked at $457M in Q4 2021. 901 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Black Creek Investment Management reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • Black Creek Investment Management sold 7,366,879 GSK shares in Q2 2022, an estimated $401M.
  • Black Creek Investment Management first reported a position in GSK in Q1 2018 and held it in 17 quarters.
  • Black Creek Investment Management's GSK position peaked at $457M in Q4 2021.
  • 901 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Black Creek Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.